• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Exelixis

Exelixis

Exelixis Inc EXEL 3 Star

Last Price$1.62Day Change (%)-6.90%
Open Price$1.75Day Change ($)-0.12
Day Range1.60–1.7552-Week Range1.60–8.41

As of Tue 09/16/2014 04:18 PM EST | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Exelixis Announces Results from the COMET-1 Phase 3 Pivotal Trial of Cabozantinib in Men with Metastatic Castration-Resistant Prostate Cancer

    Exelixis Announces Results from the COMET-1 Phase 3 Pivotal Trial of Cabozantinib in Men with Metastatic Castration-Resistant Prostate Cancer

  2. UPDATE: Apple, Tesla hit intraday records; Possible breach at Home Depot

    UPDATE: Apple, Tesla hit intraday records; Possible breach at Home Depot

  3. UPDATE: Apple, Tesla hit intraday records; Conn's falls

    UPDATE: Apple, Tesla hit intraday records; Conn's falls

  4. U.S. stocks: Futures climb ahead of ISM data

    U.S. stocks: Futures climb ahead of ISM data

  5. UPDATE: U.S. stocks: Futures climb ahead of ISM data

    UPDATE: U.S. stocks: Futures climb ahead of ISM data

  6. Is This the Year Exelixis Excels?

    The lack of early success in its lead drug's cancer trial scares the market, but we see a buying opportunity.

  7. Beware 5-Star Stocks Bearing No Moats

    Lack of competitive advantages may mean these companies aren't the bargains they seem to be.

  8. Don't Bail on Biotech

    We see opportunity as fleeing investors trigger an irrational sell-off.

  9. Pharmaceutical Firms Get the Urge to Merge

    Morningstar analysts see pharmaceuticals as 2010's hot zone for mergers and acquisitions.

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.